前列腺癌淋巴结转移检出率与肿瘤沉积大小的关系:18F-胆碱与68Ga-PSMA PET/CT对比
本研究比较了18F-胆碱与68Ga-PSMA PET/CT对前列腺癌淋巴结转移(LNM)的检出率,并分析检出率与淋巴结内肿瘤沉积(TD)大小的关系。结果显示,达到90%检出率时,18F-胆碱PET/CT所需纵向和短径分别为11.2和7.4 mm,而68Ga-PSMA PET/CT仅需6.3和4.9 mm;68Ga-PSMA的检出率显著更高。
要点
- 68Ga-PSMA PET/CT对前列腺癌淋巴结转移的检出率显著优于18F-胆碱PET/CT。
- 达到90%检出率时,68Ga-PSMA所需肿瘤沉积纵向直径(6.3 mm)明显小于18F-胆碱(11.2 mm)。
- 68Ga-PSMA引导治疗能否改善患者结局尚需进一步研究。
核心结论
- 68Ga-PSMA PET/CT在前列腺癌淋巴结转移检出方面优于18F-胆碱PET/CT。
- 该优势是否可转化为68Ga-PSMA PET引导治疗后患者结局的改善,尚待进一步研究。
研究设计与样本
- 回顾性比较2014年由18F-胆碱转换为68Ga-PSMA的两个患者队列,均因PET/CT提示LNM而行模板淋巴结清扫。
- 仅纳入小解剖亚区淋巴结清扫中1枚(条件1)或1–2枚(条件2)LNM,以实现PET/CT与组织病理学直接关联。
- 由组织病理学测定LNM内肿瘤沉积的纵向和短径,基于拟合的逻辑生长曲线模型计算50%和90%检出率对应直径(d50%、d90%)。
主要发现
- 18F-胆碱组与68Ga-PSMA组在Gleason评分、切除淋巴结数和每例淋巴结清扫亚区方面无显著差异。
- 18F-胆碱组显像时中位前列腺特异性抗原水平(3.4 ng/mL,n=34)及每例LNM数(n=34)显著高于68Ga-PSMA组(2.2 ng/mL,n=28;均P<0.05)。
- 达到d90%时,18F-胆碱PET/CT所需纵向和短径分别为11.2和7.4 mm,68Ga-PSMA PET/CT分别为6.3和4.9 mm。
- 达到d50%时,18F-胆碱PET/CT所需纵向和短径分别为5.5和3.3 mm,68Ga-PSMA PET/CT分别为3.7和2.3 mm。
- 68Ga-PSMA检出率显著更高(纵向直径P=0.005,短径P=0.04)。
关键数值与推荐
- d90%:18F-胆碱PET/CT纵向11.2 mm、短径7.4 mm;68Ga-PSMA PET/CT纵向6.3 mm、短径4.9 mm。
- d50%:18F-胆碱PET/CT纵向5.5 mm、短径3.3 mm;68Ga-PSMA PET/CT纵向3.7 mm、短径2.3 mm。
- 检出率差异:纵向直径P=0.005,短径P=0.04,68Ga-PSMA更高。
临床怎么用
- 对于前列腺癌淋巴结转移的PET/CT显像,68Ga-PSMA对较小肿瘤沉积的检出能力优于18F-胆碱。
- 解读阴性或可疑淋巴结时,应结合所用示踪剂及其对应肿瘤沉积大小的检出阈值。
- 68Ga-PSMA引导治疗对患者结局的影响尚不明确,需进一步研究验证。
局限性
- 为回顾性队列比较,两组显像时中位前列腺特异性抗原水平和每例LNM数存在显著差异。
- 仅纳入可行PET/CT与组织病理学直接关联的小解剖亚区淋巴结清扫病例。
- 68Ga-PSMA引导治疗能否改善患者结局尚未被研究证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Accurate detection of prostate cancer lymph node metastases (LNM) through PET/CT before lymphadenectomy is crucial for successful therapy. PET/CT with choline derivatives used to be the standard tool for imaging metastases, whereas 68Ga-PSMA (prostate-specific membrane antigen) PET/CT was introduced recently. Both PET techniques were investigated with respect to what extent the detection rate of LNM depends on the size of tumor deposits (TDs) within LNM. Methods: Documenting the switch from the use of 18F-choline to 68Ga-PSMA in 2014, we used 2 patient cohorts undergoing a template lymphadenectomy because of a PET/CT indicating LNM. Forty-four and 40 patients underwent PET/CT with 18F-choline or 68Ga-PSMA ligand, respectively. In total, 226 LNM (125 18F-choline, 101 68Ga-PSMA) originated from 73 salvage lymphadenectomies at biochemical recurrence and from 11 primary lymphadenectomies at radical prostatectomy. LNM eligible for direct correlation of PET/CT to histopathology were identified from lymphadenectomies conducted in small anatomic subregions, with 1 LNM (condition 1) or 1-2 LNM (condition 2). Longitudinal and short diameters of TD within LNM were determined by histopathology, allowing linking of the size of TD in LNM to the detection threshold of PET/CT. Diameters associated with a detection rate of 50% and 90% (d50%, d90%) were calculated on the basis of logistic growth curve models fitted. Results: Gleason score, number of removed LNs, and subregions for lymphadenectomy per patient did not differ significantly between the 18F-choline and 68Ga-PSMA groups. The median prostate-specific antigen level at imaging and number of LNM per patient were significantly higher in the 18F-choline group (3.4 ng/mL, n = 34) than in the 68Ga-PSMA group (2.2 ng/mL, n = 28; both P < 0.05). Longitudinal and short diameters of TD in LNM to reach d90% were 11.2 and 7.4 mm, respectively, for 18F-choline PET/CT and 6.3 and 4.9 mm, respectively, for 68Ga-PSMA PET/CT. Corresponding diameters to reach d50% were 5.5 and 3.3 mm, respectively, for 18F-choline PET/CT and 3.7 and 2.3 mm, respectively, for 68Ga-PSMA PET/CT. Detection rates were significantly higher under 68Ga-PSMA (P = 0.005 and 0.04 for longitudinal and short diameter). Conclusion: 68Ga-PSMA PET/CT is superior to 18F-choline PET/CT in the detection of LNM. Whether those results will lead to an improved patient outcome after 68Ga-PSMA PET-guided therapy needs to be investigated by further studies.
引用
- Jilg CA, Drendel V, Rischke HC, et al. Detection Rate of 18F-Choline PET/CT and 68Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes. J Nucl Med. 2019. PMID: 30683768. doi:10.2967/jnumed.118.220541
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。